Lineage Cell Therapeutics, Inc.·4

Feb 15, 7:42 PM ET

Hogge Gary S. 4

4 · Lineage Cell Therapeutics, Inc. · Filed Feb 15, 2022

Insider Transaction Report

Form 4
Period: 2022-02-11
Hogge Gary S.
SVP,Clinical & Medical Affairs
Transactions
  • Award

    Restricted Stock Units

    2022-02-11+52,08152,081 total
    Common Shares (52,081 underlying)
Footnotes (2)
  • [F1]Grant of restricted stock units under Lineage's 2021 Equity Incentive Plan. Each restricted stock unit represents a contingent right to receive one Common Share.
  • [F2]Subject to continuous service, vests in four equal annual installments beginning on February 11, 2023.

Documents

1 file
  • 4
    ownership.xmlPrimary